And so in the next two to five years, this sensor could potentially lift the pancreatic cancer survival rates from a dismal 5.5 percent to close to 100 percent, and it would do similar for ovarian and lung cancer.
E así, nos próximos dous a cinco anos este sensor podería elevar a supervivencia dun triste 5,5 % a case o 100 %, e o mesmo se podería dicir para os cancros de ovario e pulmón.